Timeline
biotech
Small Caps Today: hVIVO buys CRS Berlin, Arkadian Strategic Metals, NAHL Group, Thruvision
AstraZeneca's Tezspire hits primary endpoints in esophagitis trial
Health & Bio Today: Faron's cash pile doubles ahead of Phase 2b MDS trial, 4basebio, Eden Research
Faron's cash pile doubles ahead of Phase 2b MDS trial launch
Eden Research posts wider loss on extended 15-month period
The Premarket Brief: Brave Bison posts near-doubling of net revenue in H1, Empresaria, TPXimpact, 4basebio
4basebio signs marketing deal with viral vector CDMO Genezen
Health & Bio Today: Solvonis raises £1.3m for CNS pipeline, AstraZeneca, Nuformix, BSF Enterprise
Solvonis raises £1.3m to fund pipeline milestones
Broker upgrades Oxford Nanopore after strategy reset
Health & Bio Today: EDX Medical raises £2.7m for screening push, GSK double
GSK wins first global approval for hepatitis B drug Hibsago
Genedrive appoints two independent non-executive directors
Health & Bio Today: Broker sees upgrade scope after Oxford Nanopore's earnings beat, Diaceutics, CRISM Therapeutics
TheraCryf raises £1.05m to push lead addiction drug to clinic
Broker sees scope for upgrades after Oxford Nanopore's earnings beat
CRISM Therapeutics opens first site for glioblastoma drug trial
Diaceutics and PCC launch NGS concordance study
Health & Bio Today: Oxford Nanopore narrows losses on path to 2027 breakeven, Nuformix, Scancell Holdings
Oxford Nanopore narrows loss, says its tracking toward breakeven in 2027
Scancell wins MHRA clearance for Phase 3 melanoma trial
BioMarin to acquire RTW Bio portfolio company Alesta
Nuformix reports positive preclinical data for IPF drug candidate
AstraZeneca halts Phase III lung cancer trial after data review
BSF Enterprise strikes lab-grown leather deal for luxury cars and robots
AstraZeneca's Tagrisso combo hits survival goals in lung cancer trial
Health & Bio Today: Oxford BioDynamics lands first Gulf partnership for prostate test, Crism Therapeutics, Arecor Therapeutics
Broker sees downside risk ahead of Oxford Nanopore first results under new CEO
Arecor's AT278 diabetes data published in peer-reviewed journal
Crism Therapeutics clears site setup for glioblastoma trial
Oxford BioDynamics strikes UAE prostate test deal with Dubai clinic group
Health & Bio Today: CLS Holdings cuts guidance as valuations slide, Eco Animal Health
Avere Therapeutics to go public via NextCure reverse merger
Eco Animal Health licenses sheep toxoplasmosis vaccine from Vaxinano
BSF Enterprise on the move again as it strikes peptide licensing deal
Health & Bio Today: Hemogenyx converts Estonia LOI into binding CAR-T deal, Verici Dx, genedrive, CelLBxHealth
BSF Enterprise shares soar on licensing deal for ETSYL peptide
Independent study backs Parsortix CTC tech in brain cancer
Verici Dx wins Olink certification for proteomics services
Genedrive completes NICU recruitment for hearing-loss test
Hemogenyx signs binding Estonia deal for CAR-T therapy
Health & Bio Today: ValiRx secures second European patent for Cytolytix platform, Immupharma
Novo Nordisk teams up with Amazon in AI drug discovery partnership
ImmuPharma names Kymos Group bioanalytical partner for Kapiglucagon
ValiRx subsidiary secures second European patent notice
Health & Bio Today: Smith & Nephew execution risk, Hikma Pharmaceuticals, Solvonis Therapeutics, Novo Nordisk
Syncona highlights upcoming catalysts as trial advances
Solvonis Therapeutics' stimulant use disorder candidate outperforms in early results
Health & Bio Today: Vulcan Two grows margins through pharmacy acquisitions, CLS Holdings, Convatec, genedrive, Eden Research
More in Healthcare
Imaging Biometrics wins US academic centre subscription
A major Midwest academic medical centre has adopted Imaging Biometrics' IB Clinic software on an annual subscription, adding recurring revenue with a full 12-month contribution due in 2027.